Speaking at a press briefing post the company's yearly financial report, Mr Soriot remarked: "We couldn't make the business case work and couldn't make the investment economically viable.
AstraZeneca 'very disappointed' after scrapping £450m vaccine plant in Liverpool AstraZeneca's chief, Pascal Soriot, has said he is "very disappointed" after scapping plans for a £450m vaccine plant in Liverpool, but stressed that the numbers just didn't add up.
Mr Soriot acknowledged the Government's position, stating: "It wasn't possible for the Government to justify it, which we totally understand, and we said we couldn't justify it either.
Mr Soriot expressed pride in the company's achievements, stating: "Our company delivered a very strong performance in 2024.
The CEO of the pharmaceutical giant, Pascal Soriot, has refuted any suggestion of a fallout with the Government following the shelved project, which came to light earlier this week.
